MIAMI, Fla., Nov. 15, 2007 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announced today that its BioSource Therapeutics, Inc. (BST) subsidiary has named Jeannie Gibbs as National HIV/AIDS Community Liaison. BST manufactures and markets Nutraplete Immune System Formula Therapeutic Drink Mix. Nutraplete is the first therapeutic dietary supplement designed specifically for people living with HIV/AIDS.
According to David Miller, President, BioSource Therapeutics, Inc., "I am pleased to officially welcome Jeannie Gibbs to BST. She will serve as BST's key liaison with the HIV/AIDS community on a national basis, delivering critical marketing and communication initiatives. She will also be assisting with the development of community advisory boards, nationwide treatment education grant programs and our grassroots marketing campaign."
"Historically, nutritional supplementation for HIV patients has been inadequately addressed," said Jeannie Gibbs. "Proper nutritional supplementation is a vital factor in the patient's adherence and tolerance of antiviral drug therapy. I'm impressed with BST's determination as a company to challenge this clinical disparity and I plan to use my expertise in this arena to significantly contribute to this effort."
"I believe the science behind Nutraplete is sound," Gibbs added, "and while great advances have been made in the arena of antiretroviral therapy, the vast majority of HIV/AIDS patients in America still experience significant complications due to poor diet and subsequent micronutrient deficiencies."
About Jeannie Gibbs
Jeannie Gibbs is a Board Member of the AIDS Action Council and the Board of Health People, Inc. Jeannie has served as a member of the NYC HIV Planning Council Advisory Group and the Cornell Adult AIDS Clinical Trials Group Community Advisory Board. She is a contributing writer to the AIDS Institute's Actionlink Journal and a member of the Bronx HIV CARE Network. She is a member of the National Association of People With AIDS (NAPWA) and GNP+/ICW+, a sponsor of the International AIDS Conference. She has participated in the 12th-16th International AIDS Conferences, as well as reported on leading clinical conferences on HIV/AIDS around the world. Jeannie has been a long time advocate of clinically rational nutritional supplementation for HIV/AIDS infection.
About Nutraplete
Nutraplete's Immune System Formula is the first therapeutic dietary supplement designed specifically for people living with HIV/AIDS. It is a multi-nutritional supplement, designed to address AIDS Wasting Syndrome. It works in conjunction with antiviral therapies and assists patients in the adherence and tolerance of treatments. Nutraplete is a "functional food" that encourages the restoration of lean body mass, can inhibit pro-oxidative stress, and improve immune function. Nutraplete is available by prescription, and has started the application process for inclusion with Medicaid and AIDS Drugs Assistance Program (ADAP) formularies. Nutraplete is distributed nationally by Allion Healthcare, Inc. (Nasdaq:ALLI) under its MOMS Pharmacy trade name. www.momspharmacy.com
About Galea Life Sciences, Inc.
Galea Life Sciences, Inc. (Pink Sheets:GLSN) is currently a non-reporting over-the-counter publicly traded company. GLSN identifies and acquires new and innovative nutraceutical product and dietary supplement companies with outstanding growth potential. GLSN's focus is in the emerging scientific field of advanced nutritional supplements designed to support traditional medical treatments and therapies. BioSource Therapeutics, Inc. (BST), a GLSN subsidiary, is an entrepreneurial life sciences company. BST specializes in the formulation, manufacturing, marketing and distribution of innovative dietary supplements that benefit people undergoing medical treatments and therapies. www.nutraplete.com